To study LV mass index and to evaluate the prevalence of LVH, and risk factors for its development, in type 2 DM patients with and without micro-albuminuria

Authors

  • Pradeep Kumar Vyas Dept. Of Critical Care Medicine, Holy Family Hospital Bandra West Mumbai, Maharashtra India 4500050
  • Gurudas Pundpal Dept. Of Critical Care Medicine, Holy Family Hospital Bandra West Mumbai, Maharashtra India 4500050
  • Krutharth Kanojia Department of Medicine, Holy Family Hospital Bandra West Mumbai, Maharashtra India 4500050
  • Lipeeka Parulekarr Department of Medicine, Holy Family Hospital Bandra West Mumbai, Maharashtra India 4500050
  • Vibhav Vyas Dept. Of Critical Care Medicine, Holy Family Hospital Bandra West Mumbai, Maharashtra India 4500050
  • Arnav Uchil Dept. Of Critical Care Medicine, Holy Family Hospital Bandra West Mumbai, Maharashtra India 4500050
  • Anushka Dedhia Dept. Of Critical Care Medicine, Holy Family Hospital Bandra West Mumbai, Maharashtra India 4500050
  • Harjas singh Dham Dept. Of Critical Care Medicine, Holy Family Hospital Bandra West Mumbai, Maharashtra India 4500050

Keywords:

DIABETES, CVS, LV MASS, ALBUMINURIA, MICRO-ALBUMINURIA

Abstract

Diabetesmellitus is a heterogeneous group of diseases characterized by chronic elevation of glucose in the blood, the body is unable to produce enough insulin for its own needs, either because of impaired insulin secretion, impaired insulin action, or both. Diabetes affects around 300 million people world-wide and is increasing exponentially. Chronic exposure to high blood glucose is a leading cause of renal failure, visual loss and a range of other types of tissue damage. Diabetes also predisposes to arterial disease and is often accompanied by hypertension, lipid disorders and obesity. Many cases of diabetes and almost all of its unwanted long-term consequences are potentially avoidable diabetes is associated with cardiac death. LVH is an independent risk factor for cardiac events. Here we are presenting data from study done at Holy Family hospital Mumbai India

Downloads

Download data is not yet available.

References

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 andprojections for 2030. Diabetes Care 2004 May; 27(5):1047–53.

Evans JM, Wang J, Morris AD. Comparison of cardiovascular risk between patients with type 2 diabetes andthose who had had a myocardial infarction: cross sectional and cohort studies. Br Med J 2002 Apr 20;324(7343):939-42.

Kadiri S, Salako BL. Cardiovascular risk factors in middle aged Nigerians. East Afr Med J 1997 May;74(5):303-6.

Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001Mar; 141(3):334-41.

Pontremoli R, Leoncini G, Ravera M, Viazzi F, Vettoretti S, Ratto E, et al. Microalbuminuria, cardiovascular,and renal risk in primary hypertension. J Am Soc Nephrol 2002 Nov; 13 Suppl 3:S169–72.

Rutter MK, McComb JM, Forster J, Brady S Marshall SM. Increased left ventricular mass index and nocturnalsystolic blood pressure in patients with Type 2 diabetes mellitus and microalbuminuria. Diabet Med 2000 Apr;17(4):321–25.

Downloads

Published

2026-03-03

How to Cite

Vyas, P. K., Pundpal, G., Kanojia, K., Parulekarr, L., Vyas, V., Uchil, A., … Dham, H. singh. (2026). To study LV mass index and to evaluate the prevalence of LVH, and risk factors for its development, in type 2 DM patients with and without micro-albuminuria. Clinical Images and Case Reports, 4(02), 01–31. Retrieved from https://www.visionpublisher.info/index.php/cicr/article/view/295

Issue

Section

Articles